Biosafety testing of GMP master cell banks and retroviral vectors funding for option year 2
Ended Awarded Last action
- Contract number
- HHSN26100017
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- NIHCA2009015 Solicitation number
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$121,322 | |
| Original award | $121,322 |
Quick answers
Who was awarded contract HHSN26100017?
HHSN26100017 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on June 13, 2011.
How much is contract HHSN26100017 worth?
The government has obligated $0 on HHSN26100017.
Is contract HHSN26100017 an order under another contract?
Yes. HHSN26100017 is a delivery order under HHSN261200900022I, an indefinite delivery contract.
Was contract HHSN26100017 competed?
The extent of competition for HHSN26100017 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award